The global hyperlipidemia drugs market is witnessing steady growth as healthcare systems place greater emphasis on cardiovascular disease prevention, early diagnosis, and long-term lipid management. According to recent market analysis, the global hyperlipidemia drugs market was valued at USD 24.42 billion in 2025 and is projected to grow from USD 25.05 billion in 2026 to USD 30.76 billion by...